1. Home
  2. AZTR vs SNOA Comparison

AZTR vs SNOA Comparison

Compare AZTR & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • SNOA
  • Stock Information
  • Founded
  • AZTR 2014
  • SNOA 1999
  • Country
  • AZTR United States
  • SNOA United States
  • Employees
  • AZTR N/A
  • SNOA N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • SNOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTR Health Care
  • SNOA Health Care
  • Exchange
  • AZTR Nasdaq
  • SNOA Nasdaq
  • Market Cap
  • AZTR 3.2M
  • SNOA 3.6M
  • IPO Year
  • AZTR 2023
  • SNOA 2007
  • Fundamental
  • Price
  • AZTR $0.29
  • SNOA $2.62
  • Analyst Decision
  • AZTR
  • SNOA
  • Analyst Count
  • AZTR 0
  • SNOA 0
  • Target Price
  • AZTR N/A
  • SNOA N/A
  • AVG Volume (30 Days)
  • AZTR 4.7M
  • SNOA 60.4K
  • Earning Date
  • AZTR 03-14-2025
  • SNOA 02-14-2025
  • Dividend Yield
  • AZTR N/A
  • SNOA N/A
  • EPS Growth
  • AZTR N/A
  • SNOA N/A
  • EPS
  • AZTR N/A
  • SNOA N/A
  • Revenue
  • AZTR $97,500.00
  • SNOA $13,547,000.00
  • Revenue This Year
  • AZTR N/A
  • SNOA $23.89
  • Revenue Next Year
  • AZTR N/A
  • SNOA $25.45
  • P/E Ratio
  • AZTR N/A
  • SNOA N/A
  • Revenue Growth
  • AZTR N/A
  • SNOA 11.81
  • 52 Week Low
  • AZTR $0.23
  • SNOA $2.44
  • 52 Week High
  • AZTR $38.10
  • SNOA $9.40
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 44.02
  • SNOA 44.30
  • Support Level
  • AZTR $0.24
  • SNOA $2.59
  • Resistance Level
  • AZTR $0.59
  • SNOA $3.04
  • Average True Range (ATR)
  • AZTR 0.05
  • SNOA 0.17
  • MACD
  • AZTR 0.01
  • SNOA 0.00
  • Stochastic Oscillator
  • AZTR 10.56
  • SNOA 11.54

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

Share on Social Networks: